GeoVax Labs - Stock Price History | GOVX

Historical daily share price chart and data for GeoVax Labs since 2021 adjusted for splits. The latest closing stock price for GeoVax Labs as of September 27, 2021 is 4.33.
  • The all-time high GeoVax Labs stock closing price was 8.44 on February 17, 2021.
  • The GeoVax Labs 52-week high stock price is 8.71, which is 101.2% above the current share price.
  • The GeoVax Labs 52-week low stock price is 2.56, which is 40.9% below the current share price.
  • The average GeoVax Labs stock price for the last 52 weeks is 4.52.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
GeoVax Labs Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 1.4217 0.2210 5.7300 0.2210 3.3800 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.027B $0.002B
GeoVax Labs Inc. is a clinical-stage biotechnology company. It engages in developing human vaccines against infectious diseases and cancer using a novel patented Modified Vaccinia Ankara-Virus Like Particle based vaccine platform. GeoVax Labs Inc. is based in ATLANTA, GA.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29